A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study)

INTRODUCTION AND HYPOTHESIS: The objective of this study was to assess the tolerability and treatment preference in patients with overactive bladder (OAB) treated with mirabegron or tolterodine. METHODS: This was a two-period, 8-week crossover, double-blind, phase IV study (PREFER; NCT02138747) in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Staskin, David, Herschorn, Sender, Fialkov, Jonathan, Tu, Le Mai, Walsh, Terry, Schermer, Carol R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780540/
https://www.ncbi.nlm.nih.gov/pubmed/28620791
http://dx.doi.org/10.1007/s00192-017-3377-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780540/
https://www.ncbi.nlm.nih.gov/pubmed/28620791
http://dx.doi.org/10.1007/s00192-017-3377-5

Ejemplares similares